Intensifying insulin therapy in patients with type 2 diabetes mellitus

American Journal of Medicine

Volumn 118, Issue 5 SUPPL., 2005, Pages 21-26

  Hirsch, Irl B ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Glycemic variability; Insulin therapy; Lag times; Oxidative stress; U 500 insulin

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

ARTICLE; BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 17844377294     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.04.011     Document Type: Article

References (28)

1. UK Prospective Diabetes Study Group Effect of intensive blood glucose with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 837 853
2. S.E. Inzucchi Oral antihyperglycemic therapy for type 2 diabetes scientific review JAMA 287 2002 360 372
3. A.J. Garber, D.S. Donovan Jr, P. Dandona, S. Bruce, J.S. Park Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes J Clin Endocrinol Metab 88 2003 3598 3604
4. R.A. DeFronzo, A.M. Goodman Multicenter Metformin Study Group Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus N Engl J Med 333 1995 541 549
5. L.A. Gavin, J. Barth, D. Arnold, R. Shaw Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control Endocr Pract 6 2000 305 310
6. American Diabetes Association Standards of medical care in diabetes Diabetes Care 27 2004 S15 S35
7. American College of Endocrinology American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control Endocr Pract 8 suppl 1 2002 5 11
8. S.H. Saydah, J. Fradkin, C.C. Cowie Poor control of risk factors for diabetes among adults with previously diagnosed diabetes JAMA 291 2004 335 342
9. The Diabetes Control and Complications Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
10. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial Diabetes 44 1995 968 983
11. The Diabetes Control and Complications Research Group Implementation protocols in the Diabetes Control and Complications Trial Diabetes Care 18 1995 361 376
12. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
13. A. Risso, F. Mercuri, L. Quagliaro Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture Am J Physiol Endocrinol Metab 281 2001 E924 E930
14. L. Quagliaro, L. Piconi, R. Assalone Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells the role of protein kinase C and NAD(P)H-oxidase activation Diabetes 52 2003 2795 2804
15. D.S. Fong, L. Aiello, T.W. Gardner Position statement retinopathy in diabetes Diabetes Care 27 2004 S84 S87
16. American Diabetes Association Position statement nephropathy in diabetes Diabetes Care 27 2004 S79 S83
17. D.E. Dewitt, I.B. Hirsch Outpatient therapy for type 1 and type 2 diabetes scientific review JAMA 289 2003 2254 2264
18. J.S. Skyler Insulin treatment H.E. Lebovitz Therapy for Diabetes Mellitus and Related Disorders 4th ed 2004 American Diabetes Association Alexandria, VA 207 223
19. M.C. Riddle, J. Rosenstock, J. Gerich The Treat-to-Target Trial randomized addition of glargine or human NPH insulin to oral therapy of type 1 diabetic patients Diabetes Care 26 2003 3080 3086
20. 1c. Diabetes Care 23 2000 1236 1241
21. S. Mudaliar, F.A. Lindberg, M. Joyce Insulin aspart (B28 Asp-insulin) a fast-acting analog of human insulin Diabetes Care 22 1999 1501 1506
22. M.R. Burge, K.R. Castillo, D.S. Schade Meal composition is a determinant of lispro-induced hypoglycemia in IDDM Diabetes Care 20 1997 152 155
23. L.C. Hay, E.G. Wilmshurst, G. Fulcher Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus the results of continuous glucose monitoring Diabetes Technol Ther 5 2003 19 26
24. P. Raskin, B.W. Bode, J.B. Marks Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes a randomized, parallel-group, 24-week study Diabetes Care 26 2003 2598 2603
25. I.B. Hirsch Insulin analogues N Engl J Med 352 2005 174 183
26. P. D'Eliseo, J. Blaauw, Z. Milicevic, J. Wyatt, D.A. Ignaut, J.K. Malone Patient acceptability of a new 3.0 ml pre-filled insulin pen Curr Med Res Opin 16 2000 125 133
27. T.S. Knee, D.F. Seidensticker, J.L. Walton A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance a case series Endocr Pract 9 2003 181 186
28. R. Garg, I.G. Lawrence, M.O. Akinsola Improved glycemic control in severely insulin resistant, insulin-treated diabetic patients with U500 human actrapid over two year follow-up [abstract] Diabetologia 47 suppl 1 2004 A58